1 potential applications for drug design for cystic fibrosis treatment. Based on the crystal structure of human CFTR’s NBD1
2 approach to construct the human CFTR’s NBD1–NBD2
heterodimeric complex based on the crystal structure of human
CFTR’s NBD1 and a modeled structure of human CFTR’s NBD2 built
by using NBD1 as a mold.
3 Our method overcomes the backbone clashing
problem and requires noa priori knowledge of the dimeric structure of a homologous protein